(Total Views: 512)
Posted On: 10/15/2020 6:53:33 PM
Post# of 149372
The quote says clearly Dr. Hahn supports companies sharing data with the public. That's the first thing I want.
If safety and favorable risk/benefit are truly enough for an EUA, I would expect him to support an EUA for leronlimab. Or at least, as he promises in the quote, an explanation of his rationale for declining.
If safety and favorable risk/benefit are truly enough for an EUA, I would expect him to support an EUA for leronlimab. Or at least, as he promises in the quote, an explanation of his rationale for declining.
(4)
(0)Scroll down for more posts ▼
